Raasch, Waltera; Bartels, Torstena; Schwartz, Christophera; Häuser, Waltera; Rütten, Hartmutb; Dominiak, Petera
aInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck and bAventis Pharma Deutschland GmbH, Cardiovascular Disease Group, Frankfurt, Germany.
Sponsorship: The following companies supported this study by supplying a grant or test substances: AstraZeneca (Wedel, Germany), Aventis Pharma (Frankfurt, Germany), Bristol-Myers Squibb (München, Germany), and MSD Sharp & Dohme (Haar, Germany).
Correspondence and requests for reprints to Walter Raasch PhD, Institute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. Tel: + 49 451 5002698, fax: + 49 451 5003327, e-mail:[email protected]
Received 5 April 2002 Revised 8 July 2002 Accepted 21 August 2002